New York State home page
The last week of December we spent indoors with a couple of hundred rough sleepers and a lot of volunteers in an annual Christmas project run by Crisis. So for a week no cleaner could hose us out of our sleeping pitch (see blog of 8 December “Hosed out of our sleeping pitch”), and no employee could tell us to stay away until 1.00am due to there being a “function” (see, for example, blog of 5 December “On red alert”). Still, yesterday Declan decided it was better if we left the Catholic Manna Centre at 10.15am after a homeless guy sat provocatively in his chair, beside our bags (see, for example, blog of 19 June “Declan assaulted in the Manna Centre”) – on Saturday, a homeless guy sat in my chair during lunch shouting, among other things, “Jesus is my savoir”.
And this evening, while at a computer in our local council’s Idea Store Whitechapel library, I was pushed quite hard by a guy after I refused to let him borrow my USB drive – we often run into trouble in this library, especially with internet access and computer bookings (see blog of 13 October “Letter to the Leader of Tower Hamlets Council”).
For the last week I have been working on law and policy in New York State for our website in support of embryonic stem cell research and therapeutic cloning, also known as somatic cell nuclear transfer (for more about the campaign website see blog of 1 November “Can a cell have a soul?”). In fact, I have now finalised the content of my New York State home page, a snag of which is presented below in a page from the Greenpeace International website. As soon as I have the few New York State snags done, I will quickly build a website loosely based on Greenpeace International and Greenpeace UK which I will then upload to a free hosting service. This snag cannot be read so below it I have transcribed the content. (The blog of 18 November, “Our sleeping pitch is soaked”, includes a snag of a page from the NAC website suspended on 8 March.)
The caption of the picture reads: Mike Discipio, who was made a quadriplegic in a swimming accident and lives in the town of Colonie. Discipio came to the Capitol in 2005 to support state legislation for human embryonic stem cell research.
The navigation menu of New York State under Law and Policy in the USA: Empire State Stem Cell Board; Advocacy efforts; New York State Catholic Conference.
And the main text:
NEW YORK STATE
On 1 April 2007, the New York State Legislature passed a budget measure that provides $600 million over 11 years to fund stem cell research. The state earmarked $100 million for fiscal year 2008, and $500 million at $50 million per year for ten years beginning in fiscal year 2009. With this funding, New York's investment in stem cell science is surpassed only by the state of California.
The initiative is administered by the Department of Health through the New York State Stem Cell Science (NYSTEM) program under the direction of the Empire State Stem Cell (ESSC) Board which is comprised of two committees: a funding and ethics committee.
The agreed-upon Enacted Budget sets a broad definition for stem cells as "stem or progenitor cells that divide and are capable of generating one or more different types of progeny". This includes human embryonic stem cells and umbilical cord cells in addition to adult stem cells. While the bill excludes funding for stem cell research for human reproductive cloning, it makes no stipulation against funding for therapeutic cloning, also known as somatic cell nuclear transfer (SCNT).
For a number of years, and spurred by the 2004 passage of Proposition 71 in California – authorising the state to spend up to $3 billion in stem cell research over ten years – NYS legislators had been trying to pass a funding initiative for stem cell research. They succeeded in 2007 thanks to the support of former Democratic Governor Eliot Spitzer. Elected in 2006, Spitzer originally proposed a $2.1 billion Stem Cell and Innovation Fund program.
The University of Rochester (UR) played major roles in the events leading up to the 2007 legislation, both in advocacy and in crafting the provisions and scientific language contained in the bill. UR President Joel Seligman spearheaded the advocacy efforts of University Presidents and Chancellors, working with UR scientists and governmental relations staff to write a key White Paper entitled "New York and Stem Cell Research: A Scientific, Therapeutic, Economic, and Policy Analysis", released on 6 February 2006.
Critical to the advocacy efforts was New Yorkers for the Advancement of Medical Research (NYAMR), a coalition of patient advocacy groups, faith-affiliated organisations, medical colleges and biotechnology companies that have a shared interest in encouraging and funding embryonic stem cell research in New York State. This 46-member coalition includes the Parkinson's Disease Foundation, Juvenile Diabetes Research Foundation, Hadassah, the Christopher Reeve Paralysis Foundation, the Michael J Fox Foundation, the Biotechnology Association of New York, and numerous other stakeholders.
According to the website of the New York State Catholic Conference, which represents the Catholic bishops of New York State in matters of public policy, the state funding of human embryonic stem cell research and SCNT "is both fiscally irresponsible and morally indefensible". The Conference views such research as "an alarming assault on the dignity and value of human life", and supports legislation at both the state and federal levels to prohibit it. Approximately 10 percent of health care services statewide are provided by the state's 30 Catholic-sponsored hospitals and their 172 related clinics; 54 nursing homes; and 22 Catholic-sponsored home care agencies and long-term home health care programs.
The majority of New Yorkers support embryonic stem cell research, as demonstrated by a 2006 Zogby International poll which found that 84 percent of New Yorkers support embryonic stem cell research. Nearly 70 percent of those polled expressed support for state funding as a way of countering former President George W Bush's policy restricting federal funding to research that only uses human embryonic stem cell lines in existence as of 9 August 2001.